{"ticker": {"uuid": "d4c17e2b-6938-4e0a-9615-82c668e1e6f6", "symbol": "600812", "name": "North China Pharmaceutical Company.Ltd", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Go Global, Go Systemic: China Asset Management Unveils Active Investment Research 5.0", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/global-systemic-china-asset-management-080700369.html", "source_name": "GlobeNewswire", "published_at": "2026-07-23T08:07:00+00:00", "published_display": "23 Jul 2026 08:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of North China Pharmaceutical Company Ltd. Class A \u2013 SSE:600812", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxON09qZVk2bUZfMEkxWVNKWmx3OE8wYkFlOXUzaURCMXYwaG1DNkVPLUVDd0hUMmZlMXRSWng2U1dTZUJhd3A1cm5odkkydElXNDczU3VYdVNBaEhUaDd2MzNDYVk2VzlfWUk0V1JXNGRVNnhNVkFGM285dEl4ZzlPTjVZMk1uMTRDSzdHMlVJX2FnY1p2VjRNWlhKb2hST1QzbnZ4RHJRTGdub2c?oc=5", "source_name": "TradingView", "published_at": "2026-07-07T16:50:06+00:00", "published_display": "07 Jul 2026 16:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of North China Pharmaceutical Company Ltd. Class A \u2013 SSE:600812", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPUFZtZlZqc1ozQUdWeWFpNU50YU01WUw0ZXh2QWZSakdwUjI5d19NTXI5MHZ3VHFET1NnZ1hqaElteWQzU3JlaHhwUUJHU01tU0ktVGV6ZVZxakpWTGxydFVidmxCbmRCWTNrMHFwT1ItNkFkVTJtaHdIOC1uNE1BRmNLYThqMWRwTEVHU3I2a2xERjhtLWRfM3I5SWxJT0px?oc=5", "source_name": "TradingView", "published_at": "2026-07-07T16:28:48+00:00", "published_display": "07 Jul 2026 16:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of North China Pharmaceutical Company Ltd. Class A \u2013 SSE:600812", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQSktIYjBwamVnMDZkQjRZNUVMeVJ6a0tiV2lwckFpSlh1VFV3UFVlZW1ZT2xSMzFhSzJyczdNbnRLVF85NTk0QWlnaU40bEV2ZDlaSkRrRTVkay1nbjI5cENlU09MNVBUVVJjSmlZNDdjdEpzcm5wcmdvRTJPWVhtRE1tNWx3ckkzUG41d3N2cjczeFV5bEpQY2FFbXQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-07T16:00:01+00:00", "published_display": "07 Jul 2026 16:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Antipollution decree in China shutters drug manufacturing in Shijiazhuang until year-end", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPRXFRVlc3Z3hBcFJzNEJDMmNUSEppOUh1OGZxanU0VmI4YmJUeTIyV3FrQ0xjdDN3TkNHT19pVVJVakNiVzBicGppWkhjM2lKQ1VGeEV6TU9kQzZuQ0V2SEZlVElRdUh4OFA5cS1qQXczVVMzekxNZjhBMTI5Ung2ZWpHTHR5SFhaZm5GMTNDcjFWaWJYYVA1bS1NNWRiUHdtRjZjT0dxeUxveFNLTG43UHBVd0RBRGxXZGdROExrbnc0LXI0?oc=5", "source_name": "Fierce Pharma", "published_at": "2016-11-21T08:00:00+00:00", "published_display": "21 Nov 2016 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Go Global, Go Systemic: China Asset Management Unveils Active Investment Research 5.0", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/global-systemic-china-asset-management-080700369.html", "source_name": "GlobeNewswire", "published_at": "2026-07-23T08:07:00+00:00", "published_display": "23 Jul 2026 08:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of North China Pharmaceutical Company Ltd. Class A \u2013 SSE:600812", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxON09qZVk2bUZfMEkxWVNKWmx3OE8wYkFlOXUzaURCMXYwaG1DNkVPLUVDd0hUMmZlMXRSWng2U1dTZUJhd3A1cm5odkkydElXNDczU3VYdVNBaEhUaDd2MzNDYVk2VzlfWUk0V1JXNGRVNnhNVkFGM285dEl4ZzlPTjVZMk1uMTRDSzdHMlVJX2FnY1p2VjRNWlhKb2hST1QzbnZ4RHJRTGdub2c?oc=5", "source_name": "TradingView", "published_at": "2026-07-07T16:50:06+00:00", "published_display": "07 Jul 2026 16:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of North China Pharmaceutical Company Ltd. Class A \u2013 SSE:600812", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPUFZtZlZqc1ozQUdWeWFpNU50YU01WUw0ZXh2QWZSakdwUjI5d19NTXI5MHZ3VHFET1NnZ1hqaElteWQzU3JlaHhwUUJHU01tU0ktVGV6ZVZxakpWTGxydFVidmxCbmRCWTNrMHFwT1ItNkFkVTJtaHdIOC1uNE1BRmNLYThqMWRwTEVHU3I2a2xERjhtLWRfM3I5SWxJT0px?oc=5", "source_name": "TradingView", "published_at": "2026-07-07T16:28:48+00:00", "published_display": "07 Jul 2026 16:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of North China Pharmaceutical Company Ltd. Class A \u2013 SSE:600812", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQSktIYjBwamVnMDZkQjRZNUVMeVJ6a0tiV2lwckFpSlh1VFV3UFVlZW1ZT2xSMzFhSzJyczdNbnRLVF85NTk0QWlnaU40bEV2ZDlaSkRrRTVkay1nbjI5cENlU09MNVBUVVJjSmlZNDdjdEpzcm5wcmdvRTJPWVhtRE1tNWx3ckkzUG41d3N2cjczeFV5bEpQY2FFbXQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-07T16:00:01+00:00", "published_display": "07 Jul 2026 16:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Antipollution decree in China shutters drug manufacturing in Shijiazhuang until year-end", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPRXFRVlc3Z3hBcFJzNEJDMmNUSEppOUh1OGZxanU0VmI4YmJUeTIyV3FrQ0xjdDN3TkNHT19pVVJVakNiVzBicGppWkhjM2lKQ1VGeEV6TU9kQzZuQ0V2SEZlVElRdUh4OFA5cS1qQXczVVMzekxNZjhBMTI5Ung2ZWpHTHR5SFhaZm5GMTNDcjFWaWJYYVA1bS1NNWRiUHdtRjZjT0dxeUxveFNLTG43UHBVd0RBRGxXZGdROExrbnc0LXI0?oc=5", "source_name": "Fierce Pharma", "published_at": "2016-11-21T08:00:00+00:00", "published_display": "21 Nov 2016 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 47, "total_relevant": 5, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 5, "score": 50, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 68, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 4.82, "latest_week": "2026-07-17", "one_week_move": 4.6, "four_week_move": 10.0, "twelve_week_move": -8.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.434487, "market_dynamics_buy_signal": false, "relative_strength": -10.273109, "fair_value_gap": -12.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 52.1853, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.6% over one week, +10.0% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 54, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 3}, {"label": "GlobeNewswire", "count": 1}, {"label": "Fierce Pharma", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}, {"label": "Earnings", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "68/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+4.6% over one week, +10.0% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Go Global, Go Systemic: China Asset Management Unveils Active Investment Research 5.0"}], "updated_at": "2026-07-23T08:22:45.266085+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}